Light therapy is one of the most effective treatments available for moderate to severe psoriasis — and one of the most underused. For people whose topical treatments have stopped working, or who want to reduce reliance on systemic medications, phototherapy is a well-established, dermatologist-recommended option worth understanding in detail.
- How light therapy works on psoriasis
- The main types: NB-UVB, broadband UVB, PUVA, and excimer
- What light therapy can realistically achieve
- Sessions, timeline, and what results look like
- Risks and how they are managed
- Clinic vs. home phototherapy
- Using light therapy alongside topical treatment
- Who light therapy is — and isn't — right for
How light therapy works on psoriasis
Phototherapy exposes psoriasis-affected skin to controlled doses of ultraviolet light. UV light penetrates the skin and acts on the immune cells responsible for the inflammatory response driving psoriasis — specifically suppressing the overactive T-cell activity that triggers rapid skin cell turnover, slowing the production cycle that generates plaques and scale.[1]
This is a fundamentally different mechanism from topical treatments. Where coal tar and salicylic acid work at the surface — slowing cell production and removing scale — phototherapy targets the immune process upstream. This is why it works for people whose topical treatments have lost effectiveness or whose psoriasis covers too large an area for topicals to be practical on their own.
The main types: NB-UVB, broadband UVB, PUVA, and excimer
Uses a specific wavelength (311–313 nm) most effective for psoriasis while minimizing exposure to wavelengths associated with burning and long-term skin damage.
- First-line phototherapy for most cases
- No medication required
- Available in clinic and home units
- Typical course: 3 sessions per week for 8–12 weeks
Uses a wider range of UV wavelengths. Less targeted than narrowband UVB — largely replaced by NB-UVB in most practices, though still available where NB-UVB equipment isn't.
- Less precise than NB-UVB
- Higher burning risk at equivalent doses
- Still effective where NB-UVB is unavailable
Combines UVA light with psoralen — a medication that sensitizes the skin to UV, significantly increasing treatment effectiveness. Psoralen is taken orally or applied topically before each session.
- More powerful than UVB alone
- Higher skin cancer risk with long-term use
- Requires closer monitoring
- Reserved for cases that don't respond to NB-UVB
Delivers a concentrated NB-UVB beam to specific plaques without exposing surrounding healthy skin. Useful for stubborn, localized areas — elbows, knees, scalp patches — that haven't responded to other treatments.
- Targets individual plaques precisely
- Fewer total sessions needed
- Not practical for widespread psoriasis
What light therapy can realistically achieve
The NPF reports that NB-UVB phototherapy clears or significantly improves psoriasis in approximately 75% of patients who complete a full course of treatment.[2] For many people this means periods of near-complete clearance — skin that looks and feels normal — lasting months before maintenance treatment is needed.
The benefits that distinguish phototherapy from topical-only approaches:
- Effective for widespread psoriasis. Topical treatments become impractical when psoriasis covers large body areas. Phototherapy treats all exposed skin simultaneously, making it the more appropriate option when psoriasis is extensive.
- Drug-free. NB-UVB requires no systemic medication. For people who want to reduce or avoid oral medications or biologics — due to cost, side effects, or preference — phototherapy provides comparable efficacy without the pharmacological burden.
- Can reduce medication dependence. Phototherapy is often used to bring severe psoriasis under control before transitioning to lower-intensity maintenance, allowing some patients to reduce systemic medications under dermatologist supervision.
- Well-tolerated long-term. NB-UVB has a well-established safety record spanning decades and remains one of the AAD's recommended treatment options at every severity level above mild.
Sessions, timeline, and what results look like
A standard NB-UVB course involves three sessions per week in a dermatologist's office or phototherapy clinic. Each session takes only a few minutes — initial exposures are very short, with duration increasing gradually as tolerance is established. Most people complete 20–30 sessions over 8–12 weeks before their dermatologist assesses response.
The timeline for visible improvement varies. Some people notice reduction in scale and itch within the first two to three weeks. More significant clearing typically becomes visible around weeks four to six. Full or near-full clearance, when it occurs, is usually apparent by the end of a complete course.
After clearance, maintenance phototherapy — reduced session frequency to sustain results — may be recommended. Without maintenance, psoriasis typically returns, though often less severely than before treatment. Remission length varies significantly between individuals.
Three visits per week for several months is a significant schedule commitment — the most common practical barrier to phototherapy. Home phototherapy units exist precisely for this reason and are covered under some insurance plans. Worth asking your dermatologist about before assuming clinic treatment is the only option.
Risks and how they are managed
Phototherapy is among the safest treatment options for moderate to severe psoriasis, but it carries real risks that require appropriate management:
- Sunburn-like reaction. The most common side effect, particularly early in treatment when dosing is being calibrated. Managed by starting with low doses and increasing gradually. Redness within 24 hours of a session should be reported so the next dose can be adjusted.
- Premature skin aging. Cumulative UV exposure accelerates photoaging over time. A long-term consideration, more relevant to PUVA than NB-UVB.
- Skin cancer risk. Long-term PUVA use is associated with increased squamous cell carcinoma risk. The risk with NB-UVB is considered low for typical treatment courses, but patients undergoing multiple courses over years are monitored accordingly.[1]
- Eye protection required. UV-protective goggles are worn during every session. For PUVA, eye protection is required throughout the day on treatment days due to the psoralen medication's sensitizing effect.
Phototherapy should always be conducted under dermatologist supervision — either directly in clinic or with a prescribed home unit and regular check-ins. Uncontrolled sun exposure is not a substitute and is not recommended as a psoriasis treatment. It lacks the dosing precision that makes phototherapy safe and effective.
Clinic vs. home phototherapy
Home NB-UVB units — panels and full-body cabinets — are available by prescription. The NPF notes that home phototherapy can be as effective as clinic treatment when used correctly and with regular dermatologist oversight.[2]
- Clinic: Direct dermatologist oversight, precise dose calibration, no upfront equipment cost. Requires scheduling and travel three times per week for months.
- Home unit: Treat on your own schedule, no travel, long-term cost savings across multiple treatment courses. Upfront equipment cost ($300–$3,000 depending on unit size). Requires discipline to follow prescribed dosing. Check insurance — some plans cover home unit costs.
Using light therapy alongside topical treatment
Phototherapy and topical treatment are frequently used together — the combination is more effective than either approach alone. Topicals address surface-level scale and barrier function while phototherapy targets the underlying immune process.
Coal tar applied before phototherapy sessions enhances UV penetration and improves treatment efficacy — a protocol recognized by the AAD as the Goeckerman regimen, used in dermatology for decades.[1] Consistent moisturizing before and after sessions also supports skin barrier integrity throughout the treatment course.
Topical corticosteroids and vitamin D analogs are often continued during phototherapy for specific problem areas requiring additional attention. Your dermatologist will determine the appropriate combination based on severity and location.
Who light therapy is — and isn't — right for
Phototherapy is particularly well-suited for people with:
- Moderate to severe plaque psoriasis covering a significant body surface area
- Psoriasis that hasn't responded adequately to topical treatments alone
- A preference to avoid or reduce systemic medications
- Guttate psoriasis — this type responds especially well to NB-UVB
- The schedule flexibility for regular sessions or consistent home unit use
Phototherapy may not be appropriate for people with:
- A personal or family history of melanoma or other skin cancers
- Lupus or other conditions causing photosensitivity
- Current use of medications that increase UV sensitivity
- Psoriasis limited to small areas where topicals are sufficient
The decision should be made with a dermatologist who can assess individual history, psoriasis severity and pattern, and overall treatment goals. For many people with moderate to severe psoriasis managing with topicals alone, phototherapy represents a meaningful step up in what's achievable.
Coal tar applied before UVB enhances penetration and results
Coal tar applied before phototherapy sessions improves UV penetration — a protocol used in dermatology for decades. Nopsor Shampoo and Pomade provide the coal tar and salicylic acid foundation for your topical routine, whether you're using phototherapy or managing with topicals alone.
See the Nopsor Treatment Set →40-day money-back guarantee for purchases at nopsor-usa.com or Amazon · No prescription needed
References
- American Academy of Dermatology — Psoriasis treatment: Phototherapy. aad.org/public/diseases/psoriasis/treatment/medications/phototherapy
- National Psoriasis Foundation — Phototherapy. psoriasis.org/phototherapy
